OTCMKTS:REPR - Repro-Med Systems Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$1.20 -0.02 (-1.64 %)
(As of 06/19/2018 03:07 AM ET)
Previous Close$1.22
Today's Range$1.18 - $1.20
52-Week Range$0.34 - $1.50
Volume20,741 shs
Average Volume34,604 shs
Market Capitalization$47.05 million
P/E RatioN/A
Dividend YieldN/A
Beta-0.66
Repro Med Systems, Inc. designs, manufactures, and markets proprietary portable medical devices and supplies primarily for the ambulatory infusion market and emergency medical applications worldwide. The company offers mechanical infusion product FREEDOM infusion systems, which include the FREEDOM60 syringe infusion driver, the FreedomEdge syringe infusion driver, HIgH-Flo subcutaneous safety needle sets, RMS precision flow rate tubing, and RMS precision flow rate controller, as well as medical suction product RES-Q-VAC, a portable medical suction system. The company sells its products directly to physician offices, hospitals, and other institutional customers, as well as through regional distributors specializing in the hospital respiratory care market. Repro Med Systems, Inc. was founded in 1980 and is headquartered in Chester, New York.

Receive REPR News and Ratings via Email

Sign-up to receive the latest news and ratings for REPR and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
SymbolOTCMKTS:REPR
CUSIPN/A
Phone845-469-2042

Debt

Debt-to-Equity RatioN/A
Current Ratio6.65
Quick Ratio5.17

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$12.24 million
Price / Sales3.78
Cash FlowN/A
Price / CashN/A
Book Value$0.18 per share
Price / Book6.67

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net Margins2.90%
Return on Equity7.97%
Return on Assets6.70%

Miscellaneous

Employees69
Outstanding Shares38,570,000

Repro-Med Systems (OTCMKTS:REPR) Frequently Asked Questions

What is Repro-Med Systems' stock symbol?

Repro-Med Systems trades on the OTCMKTS under the ticker symbol "REPR."

Who are some of Repro-Med Systems' key competitors?

Who are Repro-Med Systems' key executives?

Repro-Med Systems' management team includes the folowing people:
  • Mr. Andrew I. Sealfon, Co-Founder, Chairman, CEO, Pres and Head of R&D (Age 72)
  • Ms. Karen Fisher, CFO, Treasurer & Corp. Sec. (Age 52)
  • Dr. Fred L. Ma, Chief Medical Officer (Age 58)
  • Mr. Steven Kamphausen, Global VP of Sales & Marketing

Has Repro-Med Systems been receiving favorable news coverage?

News coverage about REPR stock has been trending somewhat positive this week, according to Accern Sentiment. Accern ranks the sentiment of news coverage by analyzing more than 20 million news and blog sources. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores closest to one being the most favorable. Repro-Med Systems earned a media sentiment score of 0.13 on Accern's scale. They also assigned media headlines about the company an impact score of 46.20 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the stock's share price in the next few days.

How do I buy shares of Repro-Med Systems?

Shares of REPR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Repro-Med Systems' stock price today?

One share of REPR stock can currently be purchased for approximately $1.20.

How big of a company is Repro-Med Systems?

Repro-Med Systems has a market capitalization of $47.05 million and generates $12.24 million in revenue each year. Repro-Med Systems employs 69 workers across the globe.

How can I contact Repro-Med Systems?

Repro-Med Systems' mailing address is 24 CARPENTER RD, CHESTER NY, 10918. The company can be reached via phone at 845-469-2042 or via email at [email protected]


MarketBeat Community Rating for Repro-Med Systems (REPR)

Community Ranking:  2.2 out of 5 (star star)
Outperform Votes:  35 (Vote Outperform)
Underperform Votes:  45 (Vote Underperform)
Total Votes:  80
MarketBeat's community ratings are surveys of what our community members think about Repro-Med Systems and other stocks. Vote "Outperform" if you believe REPR will outperform the S&P 500 over the long term. Vote "Underperform" if you believe REPR will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 6/19/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.